Collaboration aims to combine Twist’s proprietary synthetic antibody libraries and sophisticated bioinformatics expertise with Sosei Heptares’ world-leading StaR® (stabilized receptor) platform to generate novel antibody leads to disease-relevant GPCR targets SOUTH SAN FRANCISCO, Calif.–Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, […]
Research Triangle Park, NC – – EpiCypher, Inc. announces the co-exclusive licensing of CUT&RUN / CUT&Tag technology from Fred Hutchinson Cancer Research Center. This agreement strengthens EpiCypher’s intellectual property portfolio that includes CUT&RUN / CUT&Tag workflows for both Research Use Only (RUO) and diagnostics applications. EpiCypher is now firmly established as the leading commercial developer […]
SHENZHEN — MGI Tech Co., Ltd. (“MGI”), a global life science leader and innovator, is playing an instrumental role in the global battle against the omicron variant of COVID-19 with its DNBSEQ™ and ATOPlex technologies. As a responsible global company, and as omicron begins to rapidly spread around the world, MGI’s innovative equipment has been […]
– The financing will support development of a commercial instrument system based on the company’s proprietary and disruptive MAGNA™ technology. – MAGNA™ is set to unlock the field of dynamic genomics. – Funds raised from a global investor syndicate led by Lansdowne Partners and Bpifrance and supported by funds bringing additional experience in the life […]
SOUTH SAN FRANCISCO, Calif. — Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that synthetic RNA positive controls are now available for the SARS-CoV-2 Omicron (B.1.1.529/BA.1) variants first identified in South Africa. Since the initial discovery, the variant has […]
Creates a pure play Food Security company with pro forma revenue of approximately $1 billion and Adjusted EBITDA of approximately $300 million expected in its first full year post-closing. Pro forma company expected to have stronger growth through substantial cross synergies Combined company will have the enhanced geographic footprint, innovative product offerings, digitization capabilities, and […]
The partnership utilizes the highest-quality synthetic data in the market from Gretel to remove privacy bottlenecks and accelerate the development of precision medicine SAN DIEGO –Today, Gretel.ai announced a collaboration with Illumina, Inc. (NASDAQ: ILMN), the global leader in DNA sequencing and array-based technologies, to create privacy-protected, synthetic genomic data that can be accessed by medical researchers […]
Next-generation sequencing (NGS) enables a better understanding of genetic mechanisms linked to specific diseases and is helping drive personalised healthcare Preparing DNA for sequencing libraries is complex and prone to human error, which can interfere with accurate sequencing results The new AVENIO Edge System is a fully-automated solution for the sample preparation workflow, from DNA sample input […]
CARLSBAD, Calif. Overview: The Ion Torrent Oncomine Myeloid Assay GX v2* from Thermo Fisher Scientific is the first next-generation sequencing (NGS) assay that allows researchers to gather comprehensive mutational results from myeloid samples in a single day using the Ion Torrent Genexus System.* As the list of myeloid biomarkers continues to grow, rapid and streamlined solutions […]
TUCSON, Ariz. — HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, announced that it has exceeded $1 million of revenue recognized from sales of its HTG Transcriptome Panel (HTP) as of November 30, 2021. HTP was launched with commercial availability in the United […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
